Ozempic, Wegovy among drugs selected for Medicare's price negotiations
The Biden administration announced Friday that Ozempic, Wegovy and 13 additional drugs will now be covered under Medicare Part-D for price negotiations, the next round of negotiations under the Inflation Reduction Act passed by President Joe Biden in 2022.
Biden's Executive Order to lower copays for some drugs to $2 for Medicare and Medicaid enrollees is nixed by President Trump.
The Centers for Medicare & Medicaid Services Jan. 13 released its standards for the health insurance marketplaces for 2026, ...
The rescinded order directed Medicare and Medicaid to test ways to lower drug costs for enrollees. Those tests hadn’t started ...
Abe Sutton, a health policy aide in the first Trump administration, is likely to be named head of the Center for Medicare and ...
This explainer defines Medicaid work requirements, updates their current status at the federal and state levels, and ...
CMS has been dedicated to strengthening Medicaid and CHIP by helping eligible people more easily enroll and keep their ...
It opens the door for broader coverage and access to Zepbound, which is not currently covered by Medicare and many other ...
An executive order designed to lower the cost of prescription drugs was one of the measures rescinded by President Donald ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback